Literature DB >> 11867942

Functional insulin-like growth factor-1/insulin-like growth factor-1 receptor-mediated circuit in human and murine thymic epithelial cells.

Valéria de Mello Coelho1, Déa Maria Serra Villa-Verde, Désio Aurélio Farias-de-Oliveira, José Marques de Brito, Mireille Dardenne, Wilson Savino.   

Abstract

Interactions between thymocytes and thymic epithelial cell (TEC) can be modulated by growth hormone via insulin-like growth factor-1 (IGF-1). In this study, we showed IGF-1 and IGF-1 receptor mRNA expression by human and murine TEC and thymocytes. Functionally, IGF-1 stimulates extracellular matrix production by human TEC. Moreover, pretreatment of murine TEC with IGF-1 increases their adhesion to thymocytes. Interestingly, we observed an increase in the frequency of CD4-CD8-CD90+ T cells which adhered to pretreated TEC, supporting the concept that IGF-1 may also act indirectly on intrathymic T cell differentiation and migration through the thymic epithelium. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11867942     DOI: 10.1159/000048230

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  11 in total

1.  Slowing down differentiation of engrafted human myoblasts into immunodeficient mice correlates with increased proliferation and migration.

Authors:  Ingo Riederer; Elisa Negroni; Maximilien Bencze; Annie Wolff; Ahmed Aamiri; James P Di Santo; Suse D Silva-Barbosa; Gillian Butler-Browne; Wilson Savino; Vincent Mouly
Journal:  Mol Ther       Date:  2011-09-20       Impact factor: 11.454

Review 2.  Improving immunity in the elderly: current and future lessons from nonhuman primate models.

Authors:  Christine Meyer; Amelia Kerns; Kristen Haberthur; Ilhem Messaoudi
Journal:  Age (Dordr)       Date:  2011-12-20

Review 3.  Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways.

Authors:  Dennis D Taub; William J Murphy; Dan L Longo
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

Review 4.  Hormonal control of T-cell development in health and disease.

Authors:  Wilson Savino; Daniella Arêas Mendes-da-Cruz; Ailin Lepletier; Mireille Dardenne
Journal:  Nat Rev Endocrinol       Date:  2015-10-06       Impact factor: 43.330

Review 5.  Insulin-like growth factor-I regulation of immune function: a potential therapeutic target in autoimmune diseases?

Authors:  Terry J Smith
Journal:  Pharmacol Rev       Date:  2010-04-14       Impact factor: 25.468

Review 6.  Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network.

Authors:  Doug Redelman; Lisbeth A Welniak; Dennis Taub; William J Murphy
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

7.  Divergent frequencies of IGF-I receptor-expressing blood lymphocytes in monozygotic twin pairs discordant for Graves' disease: evidence for a phenotypic signature ascribable to nongenetic factors.

Authors:  Raymond S Douglas; Thomas H Brix; Catherine J Hwang; Laszlo Hegedüs; Terry J Smith
Journal:  J Clin Endocrinol Metab       Date:  2009-02-24       Impact factor: 5.958

Review 8.  Abnormal T-Cell Development in the Thymus of Non-obese Diabetic Mice: Possible Relationship With the Pathogenesis of Type 1 Autoimmune Diabetes.

Authors:  Daniella A Mendes-da-Cruz; Julia P Lemos; Geraldo A Passos; Wilson Savino
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-12       Impact factor: 5.555

9.  Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.

Authors:  Gabriel Morrhaye; Hamid Kermani; Jean-Jacques Legros; Frederic Baron; Yves Beguin; Michel Moutschen; Remi Cheynier; Henri J Martens; Vincent Geenen
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

Review 10.  Interactions Between the Neuroendocrine System and T Lymphocytes in Diabetes.

Authors:  Luz Andreone; María Laura Gimeno; Marcelo J Perone
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-17       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.